Apyx Medical Corp reports results for the quarter ended in September - Earnings Summary

Apyx Medical

10/11/2022 14:33

* Apyx Medical Corp  APYX.OQ  reported a quarterly adjusted
loss
of 17 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 14 cents per share.
    * Revenue fell 23% to $9.11 million from a year ago;
analysts
expected $12.01 million. 
    * Apyx Medical Corp's reported EPS for the quarter was a
loss
of 17 cents​.
    * The mean earnings estimate of analysts had fallen by
about 5.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Apyx Medical Corp shares had fallen by 2.0% this
quarter and
lost 65.7% so far this year.
    * The company reported a quarterly loss of $5.76 million.
    * Wall Street's median 12-month price target for Apyx
Medical Corp
is $14.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 02:33 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.14          -0.17          Missed
 Jun. 30 2022      -0.19          -0.16          Beat
 Mar. 31 2022      -0.15          -0.17          Missed
 Dec. 31 2021      -0.11          -0.06          Beat